Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01464437 · ClinicalTrials.gov registry record · Phase 2

AMG 151 Amgen Protocol Number 20100761

A Phase 2 study of Diabetes Mellitus, sponsored by Amgen.

Completed
Registry status
Phase 2
Development phase
236
Enrollment target
20
Study locations

NCT01464437 is a Phase 2 study of Diabetes Mellitus that has completed, run by Amgen. The registered enrollment target is 236 participants, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (87% lower). The trial reports 20 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01464437, a Phase 2 study of Diabetes Mellitus, has completed, sponsored by Amgen.

COMPLETED
Registry status
Phase 2
Development phase
236 participants
Enrollment target
20
Study locations

Study Summary

This is a phase 2a, multicenter, randomized, double-blind, placebo-controlled, parallel group, fixed dose study. AMG 151 will be evaluated in subjects with type 2 diabetes treated with metformin for at least 3 months prior to randomization.

Conditions Studied

Diabetes Mellitus

Interventions

  • DRUG Placebo
  • DRUG Metformin
  • DRUG AMG 151

Study Locations (20)

California

  • Research Site - Anaheim
  • Research Site - Chula Vista
  • Research Site - Fresno
  • Research Site - Greenbrae
  • Research Site - Inglewood
  • Research Site - Lomita
  • Research Site - Los Angeles
  • Research Site - Los Angeles
  • Research Site - Palm Desert
  • Research Site - Roseville
  • Research Site - San Diego
  • Research Site - San Jose
  • Research Site - Walnut Creek
  • Research Site - Watsonville

Arizona

  • Research Site - Phoenix
  • Research Site - Tucson

Florida

  • Research Site - Bradenton
  • Research Site - Brooksville

Alabama

  • Research Site - Birmingham

Arkansas

  • Research Site - Little Rock

Trial Details

FieldValue
Enrollment Target 236 participants
Start Date 2011-09
Est. Completion 2012-12
Phase Phase 2

Sponsor

Amgen

558 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01464437

The ClinicalTrials.gov registry entry for NCT01464437 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 236 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (87% lower). The listed sponsor is Amgen, which has 558 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT01464437 reports 20 study locations spanning 5 distinct geographic areas - top geographies include California, Arizona, Florida.

Frequently Asked Questions

What is clinical trial NCT01464437 about?

NCT01464437 is a clinical study titled "AMG 151 Amgen Protocol Number 20100761". This is a phase 2a, multicenter, randomized, double-blind, placebo-controlled, parallel group, fixed dose study. AMG 151 will be evaluated in subjects with type 2 diabetes treated with metformin for at least 3 months prior to randomization.

What is the current status of trial NCT01464437?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 236 participants. The study started on 2011-09. Estimated completion is 2012-12.

What conditions does trial NCT01464437 study?

This clinical trial studies the following conditions: Diabetes Mellitus.

What interventions are being tested in trial NCT01464437?

The interventions under investigation include: Placebo (DRUG), Metformin (DRUG), AMG 151 (DRUG).

Who is sponsoring clinical trial NCT01464437?

This trial is sponsored by Amgen, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01464437 being conducted?

This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Diabetes Mellitus

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.